Related Experiment Videos
Immortalization of magnetically separated human lymphocytes by electrofusion.
R W Glaser1, H D Volk, C Liebenthal
1Department of Medical Immunology, Medical School (Charité), Humboldt University Berlin, GDR.
Summary
Human lymphocytes were immortalized by electrofusion. B cells showed high immortalization rates, and even non-B cells could form hybridomas, expanding cell line development possibilities.
Area of Science:
- Immunology
- Cell Biology
Background:
- Peripheral blood mononuclear cells (MNCs) are crucial for immune responses.
- Immortalization of lymphocytes is vital for monoclonal antibody production and cellular studies.
- Current methods for lymphocyte immortalization can be inefficient.
Purpose of the Study:
- To investigate the efficiency of electrofusion for immortalizing human peripheral blood lymphocytes.
- To determine the immortalization capacity of different lymphocyte subsets, including B cells and non-B cells.
- To compare the hybridoma formation rates across various cell populations.
Main Methods:
- Human peripheral blood mononuclear cells (MNCs) were isolated and separated using magnetic beads based on surface markers.
- Positive and negative cell fractions were subjected to electrofusion with the heteromyeloma line CB-Fu2.
- B cells were specifically isolated using anti-CD19 coated beads.
- Hybridoma clones were selected using HAT (hypoxanthine-aminopterin-thymidine) resistance.
Main Results:
- Successful immortalization of both positive and negative cell fractions from human peripheral blood lymphocytes was achieved.
- B cells, isolated via anti-CD19 beads, demonstrated high immortalization rates (10^-5 to 10^-4) even with limited cell numbers.
- Non-B cells, including T cells, also yielded HAT-resistant hybridoma clones, albeit at a lower fusion frequency.
Conclusions:
- Electrofusion is an effective method for immortalizing human peripheral blood lymphocytes.
- B cells are highly amenable to immortalization via electrofusion, enabling efficient hybridoma generation.
- The study demonstrates the potential for immortalizing non-B lymphocytes, broadening the scope of hybridoma technology.